{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:6992350",
      "entity_text" : "mf",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00748",
      "entity_text" : "group II mGlu receptor",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Application of the group II mGlu receptor agonist, DCG-IV, after the recordings, selectively blocked mf responses by 40% or greater.",
  "reading_complete" : "2020-08-03T09:52:45Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T09:49:50Z",
  "trigger" : "blocked",
  "evidence" : [ "group II mGlu receptor agonist, DCG-IV, after the recordings, selectively blocked mf" ],
  "pmc_id" : "3358719",
  "score" : 0
}